October 20, 2021 22:25 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'WhatsApp chats reveal Aryan Khan regularly indulged in illicit drugs': Court says denying bail | Priyanka Gandhi Vadra allowed to visit family of UP man who died in police custody | Drug case: Aryan Khan's bail rejected | Crops destroyed due to rains: Delhi announces Rs. 50,000 per hectare of farmland compensation to farmers | Kashmir: 2 militants and a soldier killed in Shopian gunfight
Lupin receives USFDA approval for Sevelamer Hydrochloride tablets Lupin
Image Credit: UNI

Lupin receives USFDA approval for Sevelamer Hydrochloride tablets

India Blooms News Service | @indiablooms | 17 Jun 2021, 06:19 pm

Mumbai/UNI: Pharma major Lupin on Thursday said that it has received approval for its Sevelamer Hydrochloride Tablets, 400 mg and 800 mg from the United States Food and Drug Administration (USFDA) to market a generic equivalent of Renagel Tablets, 400 mg, and 800 mg of Genzyme Corporation.

The product will be manufactured at Lupin's facility in Nagpur, India.

Sevelamer Hydrochloride Tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.

Sevelamer Hydrochloride Tablets had an estimated annual sales of USD 80 million in the US (IQVIA MAT March 2021).